Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.

Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. CMAJ. 2020 Apr 08;: Authors: Juurlink DN PMID: 32269021 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32269021?dopt=Abstract

Source: cmaj - April 7, 2020 Category: General Medicine Authors: Juurlink DN Tags: CMAJ Source Type: research

More News: Azithromycin | General Medicine | Hydroxychloroquine | SARS | Zithromax